Umbilical cord blood mesenchymal stem cells co-modified by TERT and BDNF: A novel neuroprotective therapy for neonatal hypoxic-ischemic brain damage

International Journal of Developmental Neuroscience

Volumn 38, Issue , 2014, Pages 147-154

  Zhao, Fengyan ^a   Qu, Yi ^a   Liu, Haiting ^a   Du, Baowen ^c   Mu, Dezhi ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHENGDU INSTITUTE OF BIOLOGY   (China)

Author keywords

Brain derived neurotrophic factor; Hypoxic ischemic brain damage; Telomerase reverse transcriptase; Umbilical cord blood mesenchymal stem cells

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; TELOMERASE REVERSE TRANSCRIPTASE;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHEMOATTRACTION; CONVALESCENCE; ENZYME ACTIVITY; EXCITOTOXICITY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD MESENCHYMAL STEM CELL; UMBILICAL CORD BLOOD MESENCHYMAL STEM CELL TRANSPLANTATION;

EID: 84907739738     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2014.06.014     Document Type: Review

References (106)

1. Ahmed S., Passos J.F., Birket M.J., Beckmann T., Brings S., Peters H., Birch-Machin M.A., von Zglinicki T., Saretzki G. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell. Sci. 2008, 121:1046-1053.
2. Alexanian A.R., Maiman D.J., Kurpad S.N., Gennarelli T.A. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. Stem Cells Dev. 2008, 17:1123-1130.
3. Baek S., Bu Y., Kim H., Kim H. Telomerase induction in astrocytes of Sprague-Dawley rat after ischemic brain injury. Neurosci. Lett. 2004, 363:94-96.
4. Bakshi A., Barshinger A.L., Swanger S.A., Madhavani V., Shumsky J.S., Neuhuber B., Fischer I. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: a novel method for minimally invasive cell transplantation. J. Neurotrauma 2006, 23:55-65.
5. Balaratnasingam S., Janca A. Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders. Pharmacol. Ther. 2012, 134:116-124.
6. Bermudez Y., Yang H., Saunders B.O., Cheng J.Q., Nicosia S.V., Kruk P.A. VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent. Gynecol. Oncol. 2007, 106:526-537.
7. Bischoff D.S., Makhijani N.S., Yamaguchi D.T. Constitutive expression of human telomerase enhances the proliferation potential of human mesenchymal stem cells. BioRes. Open Access 2012, 1:273-279.
8. Borlongan C.V., Glover L.E., Tajiri N., Kaneko Y., Freeman T.B. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog. Neurobiol. 2011, 95:213-228.
9. Buonocore G., Perrone S., Turrisi G., Kramer B.W., Balduini W. New pharmacological approaches in infants with hypoxic-ischemic encephalopathy. Curr. Pharm. Des. 2012, 18:3086-3100.
10. Carvalho M.M., Teixeira F.G., Reis R.L., Sousa N., Salgado A.J. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr. Stem Cell Res. Ther. 2011, 6:221-228.
11. Carson C.T., Aigner S., Gage F.H. Stem cells: the good, bad and barely in control. Nat. Med. 2006, 12:1237-1238.
12. Cho S.W., Gwak S.J., Kang S.W., Bhang S.H., Won Song K.W., Yang Y.S., Choi C.Y., Kim B.S. Enhancement of angiogenic efficacy of human cord blood cell transplantation. Tissue Eng. 2006, 12:1651-1661.
13. Cohen-Cory S., Kidane A.H., Shirkey N.J., Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev. Neurobiol. 2010, 70:271-288.
14. Dalous J., Larghero J., Baud O. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatr Res. 2012, 71:482-490.
15. Desestret V., Riou A., Chauveau F., Cho T.H., Devillard E., Marinescu M., Ferrera R., Rey C., Chanal M., Angoulvant D., Honnorat J., Nighoghossian N., Berthezene Y., Nataf S., Wiart M. In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLoS One 2013, 8:e67063.
16. Ding D., Zhou J., Wang M., Cong Y.S. Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer. FEBS J. 2013, 280:3205-3211.
17. Ding D.C., Shyu W.C., Chiang M.F., Lin S.Z., Chang Y.C., Wang H.J., Su C.Y., Li H. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol. Dis. 2007, 27:339-353.
18. Edwards A.D., Brocklehurst P., Gunn A.J., Halliday H., Juszczak E., Levene M., Strohm B., Thoresen M., Whitelaw A., Azzopardi D. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010, 340:c363.
19. Ferroni L., Gardin C., Tocco I., Epis R., Casadei A., Vindigni V., Mucci G., Zavan B. Potential for neural differentiation of mesenchymal stem cells. Adv. Biochem. Eng. Biotechnol. 2013, 129:89-115.
20. Francese R., Fiorina P. Immunological and regenerative properties of cord blood stem cells. Clin. Imaging 2010, 136:309-322.
21. Fu W., Killen M., Culmsee C., Dhar S., Pandita T.K., Mattson M.P. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 2000, 14:3-15.
22. Fu W., Lee J., Guo Z., Mattson M.P. Seizures and tissue injury induce telomerase in hippocampal microglial cells. Exp. Neurol. 2002, 178:294-300.
23. Fu W., Lu C., Mattson M.P. Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J. Neurosci. 2002, 22:10710-10719.
24. Geissler M., Dinse H.R., Neuhoff S., Kreikemeier K., Meier C. Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex. PLoS One 2011, 6:e20194.
25. Gomez-Palacio-Schjetnan A., Escobar M.L. Neurotrophins and synaptic plasticity. Curr. Top. Behav. Neurosci. 2013, 15:117-136.
26. Guerra-Crespo M., Gleason D., Sistos A., Toosky T., Solaroglu I., Zhang J.H., Bryant P.J., Fallon J.H. Transforming growth factor-alpha induces neurogenesis and behavioral improvement in a chronic stroke model. NeuroScience 2009, 160:470-483.
27. Harbert M.J., Tam E.W., Glass H.C., Bonifacio S.L., Haeusslein L.A., Barkovich A.J., Jeremy R.J., Rogers E.E., Glidden D.V., Ferriero D.M. Hypothermia is correlated with seizure absence in perinatal stroke. J. Child Neurol. 2011, 26:1126-1130.
28. Hartwig F.P., Nedel F., Collares T.V., Tarquinio S.B., Nor J.E., Demarco F.F. Telomeres and tissue engineering: the potential roles of TERT in VEGF-mediated angiogenesis. Stem Cell Rev. 2012, 8:1275-1281.
29. He W., Xu X., Lv Q., Guo L. Low dose ZD7288 attenuates the ischemia/reperfusion-induced impairment of long-termpotentiation induction at hippocampal schaffer collateral-CA1 synapses. Cell Mol. Neurobiol. 2014, 34(4):611-617.
30. Horch H.W., Katz L.C. BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat. Neurosci. 2002, 5:1177-1184.
31. Hsieh J.Y., Wang H.W., Chang S.J., Liao K.H., Lee I.H., Lin W.S., Wu C.H., Lin W.Y., Cheng S.M. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One 2013, 8:e72604.
32. Im S.H., Yu J.H., Park E.S., Lee J.E., Kim H.O., Park K.I., Kim G.W., Park C.I., Cho S.R. Induction of striatal neurogenesis enhances functional recovery in an adult animal model of neonatal hypoxic-ischemic brain injury. NeuroScience 2010, 169:259-268.
33. Indran I.R., Hande M.P., Pervaiz S. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res. 2011, 71:266-276.
34. Jellema R.K., Wolfs T.G., Lima Passos V., Zwanenburg A., Ophelders D.R., Kuypers E., Hopman A.H., Dudink J., Steinbusch H.W., Andriessen P., Germeraad W.T., Vanderlocht J., Kramer B.W. Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS One 2013, 8:e73031.
35. Jeong C.H., Kim S.M., Lim J.Y., Ryu C.H., Jun J.A., Jeun S.S. Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model. BioMed Res. Int. 2014, 2014:129145.
36. Ju Z., Rudolph K.L. Telomeres and telomerase in stem cells during aging and disease. Genome Dyn. 2006, 1:84-103.
37. Kang H.J., Choi Y.S., Hong S.B., Kim K.W., Woo R.S., Won S.J., Kim E.J., Jeon H.K., Jo S.Y., Kim T.K., Bachoo R., Reynolds I.J., Gwag B.J., Lee H.W. Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity. J. Neurosci. 2004, 24:1280-1287.
38. Keiner S., Witte O.W., Redecker C. Immunocytochemical detection of newly generated neurons in the perilesional area of cortical infarcts after intraventricular application of brain-derived neurotrophic factor. J. Neuropathol. Exp. Neurol. 2009, 68:83-93.
39. Kim E.S., Ahn S.Y., Im G.H., Sung D.K., Park Y.R., Choi S.H., Choi S.J., Chang Y.S., Oh W., Lee J.H., Park W.S. Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr. Res. 2012, 72:277-284.
40. Kim E.Y., Lee K.B., Kim M.K. The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy. BMB Rep. 2014, 47:135-140.
41. Kitazawa H., Numakawa T., Adachi N., Kumamaru E., Tuerxun T., Kudo M., Kunugi H. Cyclophosphamide promotes cell survival via activation of intracellular signaling in cultured cortical neurons. Neurosci. Lett. 2010, 470:139-144.
42. Klapper W., Shin T., Mattson M.P. Differential regulation of telomerase activity and TERT expression during brain development in mice. J. Neurosci. Res. 2001, 64:252-260.
43. Lathia J.D., Chigurupati S., Thundyil J., Selvaraj P.K., Mughal M.R., Woodruff T.M., Chan S.L., Karamyan V.T., Mattson M.P., Arumugam T.V. Pivotal role for beta-1 integrin in neurovascular remodelling after ischemic stroke. Exp. Neurol. 2010, 221:107-114.
44. Lee I.S., Jung K., Kim M., Park K.I. Neural stem cells: properties and therapeutic potentials for hypoxic-ischemic brain injury in newborn infants. Pediatr. Int. 2010, 52:855-865.
45. Lee J., Jo Y.S., Sung Y.H., Hwang I.K., Kim H., Kim S.Y., Yi S.S., Choi J.S., Sun W., Seong J.K., Lee H.W. Telomerase deficiency affects normal brain functions in mice. Neurochem. Res. 2010, 35:211-218.
46. Lee J., Sung Y.H., Cheong C., Choi Y.S., Jeon H.K., Sun W., Hahn W.C., Ishikawa F., Lee H.W. TERT promotes cellular and organismal survival independently of telomerase activity. Oncogene 2008, 27:3754-3760.
47. Lee T.H., Seng S., Li H., Kennel S.J., Avraham H.K., Avraham S. Integrin regulation by vascular endothelial growth factor in human brain microvascular endothelial cells: role of alpha6beta1 integrin in angiogenesis. J. Biol. Chem. 2006, 281:40450-40460.
48. Li J., Qu Y., Chen D., Zhang L., Zhao F., Luo L., Pan L., Hua J., Mu D. The neuroprotective role and mechanisms of TERT in neurons with oxygen-glucose deprivation. NeuroScience 2013, 252:346-358.
49. Li J., Tang B., Qu Y., Mu D. Telomerase reverse transcriptase: a novel neuroprotective mechanism involved in neonatal hypoxic-ischemic brain injury. Int. J. Dev. Neurosci. 2011, 29:867-872. (the official journal of the International Society for Developmental Neuroscience).
50. Liang X.J., Chen X.J., Yang D.H., Huang S.M., Sun G.D., Chen Y.P. Differentiation of human umbilical cord mesenchymal stem cells into hepatocyte-like cells by hTERT gene transfection in vitro. Cell Biol. Int. 2012, 36:215-221.
51. Lim J.Y., Jeong C.H., Jun J.A., Kim S.M., Ryu C.H., Hou Y., Oh W., Chang J.W., Jeun S.S. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res. Ther. 2011, 2:38.
52. Lim J.Y., Park S.I., Kim S.M., Jun J.A., Oh J.H., Ryu C.H., Jeong C.H., Park S.H., Park S.A., Oh W., Chang J.W., Jeun S.S. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and beta-catenin phosphorylation and following transplantation into the developing brain. Cell Transplant. 2011, 20:1855-1866.
53. Liu H.Y., Zhang Q.J., Li H.J., Han Z.C. Effect of intracranial transplantation of CD34+ cells derived from human umbilical cord blood in rats with cerebral ischemia. Chin. Med. J. (Engl.) 2006, 119:1744-1748.
54. Liu R., Zhang Z., Lu Z., Borlongan C., Pan J., Chen J., Qian L., Liu Z., Zhu L., Zhang J., Xu Y. Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination. Stem. Cells Dev. 2013, 22:1053-1062.
55. Madonna R., De Caterina R., Willerson J.T., Geng Y.J. Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. Eur. Heart. J. 2011, 32:1190-1196.
56. Martire A., Pepponi R., Domenici M.R., Ferrante A., Chiodi V., Popoli P. BDNF prevents NMDA induced toxicity in models of Huntington's disease the effects are genotype specific and adenosine A(2A) receptor is involved. J. Neurochem. 2013, 125(2):225-235.
57. Mattson M.P., Lovell M.A., Furukawa K., Markesbery W.R. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 1995, 65:1740-1751.
58. Morales C.P., Holt S.E., Ouellette M., Kaur K.J., Yan Y., Wilson K.S., White M.A., Wright W.E., Shay J.W. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 1999, 21:115-118.
59. Newcomb J.D., Ajmo C.T., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 2006, 15:213-223.
60. Noble E.E., Billington C.J., Kotz C.M., Wang C. The lighter side of BDNF. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R1053-R1069.
61. Park D.H., Borlongan C.V., Willing A.E., Eve D.J., Cruz L.E., Sanberg C.D., Chung Y.G., Sanberg P.R. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 2009, 18:985-998.
62. Pasapala S.A., Vishwakarma S.K., Murthy T.V., Rao T.N., Khan A.A. Potential role of stem cells in severe spinal cord injury: current perspectives and clinical data. Stem Cells Cloning 2012, 5:15-27.
63. Peng C.H., Chiou S.H., Chen S.J., Chou Y.C., Ku H.H., Cheng C.K., Yen C.J., Tsai T.H., Chang Y.L., Kao C.L. Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur. Neuropsychopharmacol. 2008, 18:128-140.
64. Pikula A., Beiser A.S., Chen T.C., Preis S.R., Vorgias D., DeCarli C., Au R., Kelly-Hayes M., Kase C.S., Wolf P.A., Vasan R.S., Seshadri S. Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study. Stroke 2013, 44:2768-2775. (a journal of cerebral circulation).
65. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2001, 2:24-32.
66. Prakash Y.S., Martin R.J. Brain-derived neurotrophic factor in the airways. Pharmacol. Ther. 2014, 143:74-86.
67. Qu Y., Duan Z., Zhao F., Wei D., Zhang J., Tang B., Li J., Yang C., Mu D. Telomerase reverse transcriptase upregulation attenuates astrocyte proliferation and promotes neuronal survival in the hypoxic-ischemic rat brain. Stroke 2011, 42:3542-3550.
68. Robertson N.J., Nakakeeto M., Hagmann C., Cowan F.M., Acolet D., Iwata O., Allen E., Elbourne D., Costello A., Jacobs I. Therapeutic hypothermia for birth asphyxia in low-resource settings: a pilot randomised controlled trial. Lancet 2008, 372:801-803.
69. Rosenkranz K., Kumbruch S., Lebermann K., Marschner K., Jensen A., Dermietzel R., Meier C. The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain. J. Neurosci. Res. 2010, 88:1223-1233.
70. Rosenkranz K., Kumbruch S., Tenbusch M., Marcus K., Marschner K., Dermietzel R., Meier C. Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats. Cell Tissue Res. 2012, 348:429-438.
71. Santhanam A.V., Smith L.A., Katusic Z.S. Brain-derived neurotrophic factor stimulates production of prostacyclin in cerebral arteries. Stroke 2010, 41:350-356.
72. Santos J.H., Meyer J.N., Skorvaga M., Annab L.A., Van Houten B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 2004, 3:399-411.
73. Schabitz W.R., Steigleder T., Cooper-Kuhn C.M., Schwab S., Sommer C., Schneider A., Kuhn H.G. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 2007, 38:2165-2172.
74. Schinder A.F., Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci. 2000, 23:639-645.
75. Seo J.H., Cho S.R. Neurorestoration induced by mesenchymal stem cells: potential therapeutic mechanisms for clinical trials. Yonsei Med. J. 2012, 53:1059-1067.
76. Shonesy B.C., Jalan-Sakrikar N., Cavener V.S., Colbran R.J. CaMKII: a molecular substrate for synaptic plasticity and memory. Prog. Mol. Biol. Transl. Sci. 2014, 122:61-87.
77. Singhapol C., Pal D., Czapiewski R., Porika M., Nelson G., Saretzki G.C. Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis. PLoS One 2013, 8:e52989.
78. Smith A.L., Alexander M., Rosenkrantz T.S., Sadek M.L., Fitch R.H. Sex differences in behavioral outcome following neonatal hypoxia ischemia: Insights from a clinical meta-analysis and a rodent model of induced hypoxic ischemic brain injury. Exp. Neurol. 2014, 254:54-67.
79. Soule J., Messaoudi E., Bramham C.R. Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem. Soc. Trans. 2006, 34:600-604.
80. Takeda Y., Mori T., Imabayashi H., Kiyono T., Gojo S., Miyoshi S., Hida N., Ita M., Segawa K., Ogawa S., Sakamoto M., Nakamura S., Umezawa A. Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation?. J. Gene. Med. 2004, 6:833-845.
81. Taran R., Mamidi M.K., Singh G., Dutta S., Parhar I.S., John J.P., Bhonde R., Pal R., Das A.K. In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources. J. Biosci. 2014, 39:157-169.
82. Terai M., Uyama T., Sugiki T., Li X.K., Umezawa A., Kiyono T. Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. Mol. Biol. Cell 2005, 16:1491-1499.
83. van Velthoven C.T., Kavelaars A., Heijnen C.J. Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr. Res. 2012, 71:474-481.
84. van Velthoven C.T., Kavelaars A., van Bel F., Heijnen C.J. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr. Res. 2010, 68:419-422.
85. Ventimiglia R., Mather P.E., Jones B.E., Lindsay R.M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 1995, 7:213-222.
86. Verina T., Fatemi A., Johnston M.V., Comi A.M. Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury. Pediatr. Neurol. 2013, 48:346-354.
87. Wang G., Su J., Li L., Feng J., Shi L., He W., Liu Y. Edaravone alleviates hypoxia-acidosis/reoxygenation-induced neuronal injury by activating ERK1/2. Neurosci. Lett. 2013, 543:72-77.
88. Wang M., Yang Y., Yang D., Luo F., Liang W., Guo S., Xu J. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009, 126:220-232.
89. Wang S., Cheng H., Dai G., Wang X., Hua R., Liu X., Wang P., Chen G., Yue W., An Y. Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury. Brain Res. 2013, 1532:76-84.
90. Wang Y., Deng Y., Zhou G.Q. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 2008, 1195:104-112.
91. Wang Z., Deng Q., Zhang X., Zhang J. Treatment of injured neurons with bone marrow stem cells cotransfected by hTERT and Ad-BDNF in vitro. J. Mol. Neurosci. 2009, 38:265-272.
92. Wang Z., Zhan J., Wang X., Gu J., Xie K., Zhang Q., Liu D. Sodium hydrosulfide prevents hypoxia-induced behavioral impairment in neonatal mice. Brain Res. 2013, 1538:126-134.
93. Xia G., Hong X., Chen X., Lan F., Zhang G., Liao L. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. J. Perinat. Med. 2010, 38:215-221.
94. Yang C.C., Shih Y.H., Ko M.H., Hsu S.Y., Cheng H., Fu Y.S. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS One 2008, 3:e3336.
95. Yu S.J., Tseng K.Y., Shen H., Harvey B.K., Airavaara M., Wang Y. Local administration of AAV-BDNF to subventricular zone induces functional recovery in stroke rats. PLoS One 2013, 8:e81750.
96. Zaccagnini G., Gaetano C., Della Pietra L., Nanni S., Grasselli A., Mangoni A., Benvenuto R., Fabrizi M., Truffa S., Germani A., Moretti F., Pontecorvi A., Sacchi A., Bacchetti S., Capogrossi M.C., Farsetti A. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J. Biol. Chem. 2005, 280:14790-14798.
97. Zawadzka M., Kaminska B. Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol. Cell Neurosci. 2003, 22:202-209.
98. Zhang B., Chen L., Swartz K.R., Bruemmer D., Eum S.Y., Huang W., Seelbach M., Choi Y.J., Hennig B., Toborek M. Deficiency of telomerase activity aggravates the blood-brain barrier disruption and neuroinflammatory responses in a model of experimental stroke. J. Neurosci. Res. 2010, 88:2859-2868.
99. Zhang J., Yu Z., Yu Z., Yang Z., Zhao H., Liu L., Zhao J. rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model. Int. J. Clin. Exp. Pathol. 2011, 4:496-504.
100. Zhang M.J., Sun J.J., Qian L., Liu Z., Zhang Z., Cao W., Li W., Xu Y. Human umbilical mesenchymal stem cells enhance the expression of neurotrophic factors and protect ataxic mice. Brain Res. 2011, 1402:122-131.
101. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 2000, 106:829-838.
102. Zhao F., Qu Y., Xiong T., Duan Z., Ye Q., Mu D. The neuroprotective role of TERT via an antiapoptotic mechanism in neonatal rats after hypoxia-ischemia brain injury. Neurosci. Lett. 2012, 515:39-43.
103. Zhao J., Xu H., Tian Y., Hu M., Xiao H. Effect of electroacupuncture on brain-derived neurotrophic factor mRNA expression in mouse hippocampus following cerebral ischemia-reperfusion injury. J. Tradit. Chin. Med. 2013, 33:253-257.
104. Zhou L., Zheng D., Wang M., Cong Y.S. Telomerase reverse transcriptase activates the expression of vascular endothelial growth factor independent of telomerase activity. Biochem. Biophys. Res. Commun. 2009, 386:739-743.
105. Zhu Z., Zhang Q., Yu Z., Zhang L., Tian D., Zhu S., Bu B., Xie M., Wang W. Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo. Glia 2007, 55:546-558.
106. Zigova T., Song S., Willing A.E., Hudson J.E., Newman M.B., Saporta S., Sanchez-Ramos J., Sanberg P.R. Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant. 2002, 11:265-274.